Randy Werneth

Randy Werneth has extensive work experience in the medical technology industry. Randy is currently serving as the Chief Executive Officer at Maxwell Biomedical Inc. since May 2019. Prior to this role, they were the Chief Technology Officer at Argá Medtech SA starting from September 2019. Randy also worked as a Partner at Evolve Medtech Partners beginning in September 2018. In addition, they held the position of Venture Partner at E-merge Capital Partners starting from February 2021. Randy served as a Board Member at Adventus Ventures, LLC from October 2017.

Before their current roles, Randy played a significant role in the founding and leadership of multiple companies. Randy co-founded and served as CEO & President of Acutus Medical, Inc. from January 2011 to August 2017. At Acutus Medical, Inc., they developed innovative products to address the unmet clinical needs in the field of electrophysiology. Randy also held the position of Vice President of Research & Development at Medtronic - AF Solutions from January 2009 to December 2010.

Additionally, Randy co-founded and served as VP of Ablation Frontiers, Inc. from May 2004 to January 2009. Randy worked as the Director of R&D at Edwards Lifesciences from an unspecified date in 2002 to 2004. Randy had a consultancy role at Carmeron Health in 2002.

Overall, Randy Werneth has demonstrated expertise and leadership in various positions within the medical technology industry, contributing to the development of innovative products and driving growth in the field.

Randy Werneth attended Arizona State University from 1981 to 1986, where they pursued a Bachelor of Science (BS) degree in Engineering. Following this, they enrolled at UCLA from 1996 to 1998, obtaining a Master of Science (MSc) degree in Pre-Clinical Research.